Literature DB >> 6215327

Macroorchidism and fragile X in mentally retarded males. Clinical, cytogenetic, and some hormonal investigations in mentally retarded males, including two with the fragile site at Xq28, fra(X)(q28).

K B Nielsen, N Tommerup, H V Dyggve, C Schou.   

Abstract

One hundred and seventy eight males resident in an institution for the mentally retarded were screened clinically for the presence of macroorchidism, using the standard orchidometer. In this way 52 males with a testicular volume of 25 ml and over were found. Of these, 11 had pronounced macroorchidism (above 25 ml). All 52 males were examined cytogenetically for the fragile X. Two patients with pronounced macroorchidism showed this abnormality. Although the other nine patients with pronounced macroorchidism were reexamined with FUdR-addition to blood cultures, no further cases positive for the fragile X were found. Also, the thyroid function as well as the prolactin level in serum were investigated in all 52 males. No significant abnormalities were found. The high incidence of macroorchidism in mentally retarded males is underlined; however, it is suggested that the definition of macroorchidism should take into account several parameters.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215327     DOI: 10.1007/bf00274199

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Inherited congenital normofunctional testicular hyperplasia and mental deficiency.

Authors:  J M Cantú; H E Scaglia; M Medina; M González-Diddi; T Morato; M E Moreno; G Pérez-Palacios
Journal:  Hum Genet       Date:  1976-07-07       Impact factor: 4.132

2.  Juvenile hypothyroidism with testicular enlargement.

Authors:  Z Laron; M Karp; L Dolberg
Journal:  Acta Paediatr Scand       Date:  1970-05

3.  Screening for fragile X syndrome by testicular size measurement.

Authors:  W T Brown; P M Mezzacappa; E C Jenkins
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

4.  Significance of phenotypic and chromosomal abnormalities in X-linked mental retardation (Martin-Bell or Renpenning syndrome).

Authors:  M Jennings; J G Hall; H Hoehn
Journal:  Am J Med Genet       Date:  1980

5.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

Authors:  G Turner; A Daniel; M Frost
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

6.  Testicular size: assessment and clinical importance.

Authors:  A Prader
Journal:  Triangle       Date:  1966

7.  X-linked mental retardation with fragile X. A pedigree showing transmission by apparently unaffected males and partial expression in female carriers.

Authors:  K B Nielsen; N Tommerup; H Poulsen; M Mikkelsen
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

8.  Further delineation of X-linked mental retardation.

Authors:  D S Herbst; H G Dunn; F J Dill; D K Kalousek; L W Krywaniuk
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

10.  Testicular size and shape of 47,XYY and 47,XXY men in a double-blind, double-matched population survey.

Authors:  E Boisen
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

View more
  9 in total

1.  A family with mental retardation, variable macrocephaly and macro-orchidism, and linkage to Xq12-q21.

Authors:  J P Johnson; R Nelson; C E Schwartz
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

2.  Screening for fra(X)(q) in a population of mentally retarded males.

Authors:  U Froster-Iskenius; G Felsch; C Schirren; E Schwinger
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  A unique form of mental retardation with a distinctive phenotype maps to Xq26-q27.

Authors:  V Shashi; M N Berry; S Shoaf; J J Sciote; D Goldstein; T C Hart
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

4.  Fragile X mental retardation protein is required for programmed cell death and clearance of developmentally-transient peptidergic neurons.

Authors:  Cheryl L Gatto; Kendal Broadie
Journal:  Dev Biol       Date:  2011-05-10       Impact factor: 3.582

5.  Clinical and cytogenetic survey of institutionalized mentally retarded patients with emphasis on the fragile-X syndrome.

Authors:  M G Butler; D N Singh
Journal:  J Intellect Disabil Res       Date:  1993-04

Review 6.  The fragile X syndrome: the patients and their chromosomes.

Authors:  M A De Arce; A Kearns
Journal:  J Med Genet       Date:  1984-04       Impact factor: 6.318

Review 7.  Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.

Authors:  Gül Dölen; Mark F Bear
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

8.  Carrier detection and X-inactivation studies in the fragile X syndrome. Cytogenetic studies in 63 obligate and potential carriers of the fragile X.

Authors:  K B Nielsen; N Tommerup; H Poulsen; P Jacobsen; B Beck; M Mikkelsen
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

9.  Thyroid function in fragile-X syndrome males.

Authors:  J D Bregman; J F Leckman; S I Ort
Journal:  Yale J Biol Med       Date:  1990 Jul-Aug
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.